At CoRE, we promote the advancement of excellence in regulatory science and practices to safeguard the health and wellbeing of patients and populations.
With the ongoing COVID-19 pandemic, this mission is even more critical now. The need to ensure robust regulatory frameworks for innovative health products encompassing diagnostics, therapeutics and vaccines, is crucial to keep up with the fast pace of biomedical research and development.
With the support of the initiatives of the Centre since 2014, the Asia-Pacific region has made great strides in enhancing health and regulatory systems to meet the needs of its people. , However, much work remains to be done as the region collectively faces new public health challenges. For this purpose, CoRE has launched the Regulatory Excellence Fund.
Contributions to the Regulatory Excellence Fund will play an important role in enabling the Centre to sustainably address region-wide issues, explore new opportunities for innovation and impactful change, and promote long-lasting cooperative solutions.
Click here to read about our 6 key focus areas.